Position in GERN
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$279,718
New position
Shares Held
218,530
first reported quarter
Ownership
0.034%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#86
of 258 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Diversified Trust Co holds $33,471,666 across 42 Biotechnology names. GERN ranks #27 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
25,991 | $6,932,319 | |
| 2 | XENE |
Xenon Pharmaceuticals Inc.
|
39,222 | $2,367,439 | |
| 3 | MIRM |
Mirum Pharmaceuticals, Inc.
|
19,050 | $2,230,183 | |
| 4 | TVTX |
Travere Therapeutics, Inc.
|
35,281 | $2,004,313 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,481 | $1,547,002 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
41,966 | $1,401,244 | |
| 7 | RLAY |
Relay Therapeutics, Inc.
|
66,194 | $1,238,489 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
46,194 | $1,168,708 |
All Filings in GERN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $279,718 | 218,530 | Shares | Sole | 2026-07-17 | |
| No filing history on record for this holder in this stock. | ||||||